Prenumeration
A study involving athletes has shown that Enzymatica’s oral spray, ColdZyme, significantly shortens the duration of upper respiratory tract infections and reduces symptom severity. These results are likely explained by a reduced viral load, which was also shown in a recent in vitro study with ColdZyme. To gain deeper insights, BioStock spoke with the principal investigators of both studies, Professor Glen Davison and Professor Doris Wilflingseder.
Read more at biostock.se:
https://www.biostock.se/en/2025/05/the-science-behind-coldzyme-insights-from-professors/
Follow BioStock
Stay updated with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow us on social media: LinkedIn and FaceBook!
About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.
BioStock – Connecting Innovation & Capital.